Changes in nasal leukocytes and epithelial cells associated with topical beclomethasone treatment.
BACKGROUND
We had previously observed that changes in nasal cytology were associated with specific clinical patterns in cross-sectional studies of allergy clinic patients. In the present study, we sought to determine whether specific cytologic changes occurred with antiinflammatory therapy in a controlled setting in a prospective manner.


OBJECTIVE
To examine changes in nasal leukocytes and epithelial cells associated with topical beclomethasone treatment in allergic rhinitis patients. Specifically we tested the hypothesis that number of nasal leukocytes relative to epithelial cell numbers are altered by topical beclomethasone treatment.


METHODS
Adult volunteers (n=26) with symptoms consistent with allergic rhinitis and positive aeroallergen skin tests were enrolled for treatment with either beclomethasone or placebo nasal spray. Sprays were allocated in a double-blind manner and were prescribed to be administered over a 2-week period. Baseline quality of life, nasal cytograms, and mucosal physical appearance scores were obtained at baseline and at the end of the treatment period. Changes in various nasal leukocytes and epithelial cell types were analyzed for association with active treatment using bivariate and multivariate analysis.


RESULTS
Total leukocytes showed greater decreases with beclomethasone treatment than with placebo. Total epithelial cells on the other hand showed an increase with active treatment compared with placebo treatment. In multivariate analysis, the changes in both total leukocytes and total epithelial cells showed independent associations with beclomethasone treatment. Combining these two variables into a single leukocyte per epithelial ratio resulted in variable with values showing a significant decreases associated with beclomethasone treatment compared with placebo treatment (P = .03).


CONCLUSIONS
The administration of topical corticosteroids results in decreases in total leukocytes and this decrease is of enhanced significance when adjusted for the quantities of associated epithelial cells. Further investigation relating to the quantities of total nasal leukocytes in inflammatory nasal diseases may be helpful in gauging disease activity and monitoring treatment modalities.
Lin
R Y
RY
Department of Medicine, Saint Vincents Hospital & Medical Center of New York, New York Medical College, 10011, USA.
Nahal
A
A
Lee
M
M
Menikoff
H
H
D000287:Administration, Topical; D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D001507:Beclomethasone / Q000008:administration & dosage* / Q000627:therapeutic use*; D004311:Double-Blind Method; D004804:Eosinophils / Q000187:drug effects; D004847:Epithelial Cells / Q000187:drug effects*; D006801:Humans; D007962:Leukocytes / Q000187:drug effects*; D008875:Middle Aged; D009297:Nasal Mucosa / Q000166:cytology*; D012130:Respiratory Hypersensitivity / Q000188:drug therapy; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy
D001507:Beclomethasone